Top Markets
Coin of the day
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.

InNexus Biotechnology, Inc.

IXSBF
Classificação em ações #41696
InNexus Biotechnology, Inc. is a development-stage company dedicated to... InNexus Biotechnology, Inc. is a development-stage company dedicated to advancing and commercializing monoclonal antibodies. Its efforts are underpinned by its proprietary Dynamic Cross Linking (DXL) technology. This DXL platform is designed to boost the therapeutic efficacy of conventional monoclonal antibody treatments by strengthening their binding to target antigens, amplifying their effector functions, and endowing them with novel properties. InNexus's development portfolio features several investigational therapies: DXL625: A monoclonal antibody currently in late-stage pre-clinical development, engineered for superior binding kinetics and enhanced effector functions, intended for treating B-cell non-Hodgkin's lymphoma (NHL). DXLr120: A recombinant DXL anti-CD20 antibody also being developed for B-cell NHL. DXL702: A monoclonal antibody targeting metastatic breast cancer. DXL1218: An agent designed to target the epidermal growth factor receptor (EGFR), an antigen frequently overexpressed in metastatic colorectal cancer and squamous cell carcinomas of the head and neck. The company also maintains strategic partnerships with XERIS Pharmaceuticals, Genhelix, Evogenix, Affimed, and Corixa. InNexus Biotechnology, Inc. is based in Vancouver, Canada.
Preço da ação
$0.0001
Última sincronização: 2025-11-07
Valor de mercado
$12.63K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
CA
Negociar InNexus Biotechnology, Inc. (IXSBF)

Categoria

Histórico de preços das ações de InNexus Biotechnology, Inc. (IXSBF)
Preço de fecho mais alto: $0.00 em 2025-11-01

Preço de fecho mais baixo: $0.54 em 2005-01-01
Histórico de preços das ações da InNexus Biotechnology, Inc. de 2005 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 0.00%
2025 0.00%
2024 9,900.00%
2023 -98.02%
2022 -49.50%
2021 809.09%
2020 1,000.00%
2019 -99.00%
2018 0.00%
2017 0.00%
2016 20.00%
2015 -89.80%
2014 45.43%
2013 -9.43%
2012 -75.12%
2011 -93.68%
2010 -30.02%
2009 -1.01%
2008 -76.04%
2007 -65.32%
2006 182.90%
2005 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$59.08 62.03%
US
$49.68 72.21%
SE
$184.45 43.36%
FR
$62.39 4.91%
IT
$113.04 55.27%
US